Fast Locator 2012-2013: DPT Laboratories - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2012-2013: DPT Laboratories





DPT is a contract development and manufacturing organization (CDMO) specializing in sterile and non-sterile semi-solid and liquid dosage forms. DPT provides fully integrated development, manufacturing and packaging solutions for biopharmaceutical and pharmaceutical products. DPT is the source for semi-solid and liquids — from concept to commercialization and beyond.

Drug development services range from pre-formulation, formulation and biopharmaceutical development, analytical development and validation, through process development.

Production capabilities include five cGMP facilities, clinical trial materials, full scale commercial production, controlled substance registration Class II – IV, and complete supply chain management.

Packaging services encompass engineering and procurement resources necessary for conventional and specialized packaging.

Contact:

www.DPTLabs.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here